Assicurazioni Generali SpA Receives “Hold” Rating from Societe Generale (G)

Societe Generale restated their hold rating on shares of Assicurazioni Generali SpA (BIT: G) in a report released on Tuesday, Stock Ratings Network.com reports. Societe Generale currently has a €14.50 ($18.83) price objective on the stock.

Several other analysts have also recently commented on the stock. Analysts at Banca Akros reiterated a hold rating on shares of Assicurazioni Generali SpA in a research note to investors on Wednesday, May 29th. Separately, analysts at Banca IMI reiterated a hold rating on shares of Assicurazioni Generali SpA in a research note to investors on Friday, May 24th. They now have a €13.50 ($17.53) price target on the stock. Finally, analysts at Mediobanca SpA reiterated a neutral rating on shares of Assicurazioni Generali SpA in a research note to investors on Tuesday, May 21st. They now have a €15.00 ($19.48) price target on the stock.

Six analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus price target of €13.14 ($17.06).

Assicurazioni Generali SpA (BIT: G) traded down 2.71% on Tuesday, hitting €13.9900. Assicurazioni Generali SpA has a 52-week low of €8.4300 and a 52-week high of €14.9700. The stock’s 50-day moving average is currently €0.00. The company has a market cap of €21.555 billion and a price-to-earnings ratio of 247.93.

Assicurazioni Generali SpA is an Italy-based company engaged in the insurance and financial products sector.

Latest News

MUSE Price Hits $0.67 on Top Exchanges
MUSE Price Hits $0.67 on Top Exchanges
Contrasting Vulcan Materials  & United States Lime & Minerals
Contrasting Vulcan Materials & United States Lime & Minerals
VALLOUREC SA/S  & Argan  Critical Analysis
VALLOUREC SA/S & Argan Critical Analysis
$551.05 Million in Sales Expected for Bio-Rad Laboratories, Inc. Class A Common Stock  This Quarter
$551.05 Million in Sales Expected for Bio-Rad Laboratories, Inc. Class A Common Stock This Quarter
Zacks: Brokerages Expect Burlington Stores Inc  to Announce $0.96 Earnings Per Share
Zacks: Brokerages Expect Burlington Stores Inc to Announce $0.96 Earnings Per Share
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect OncoSec Medical  Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect OncoSec Medical Stock Price


© 2006-2018 Ticker Report. Google+.